Page last updated: 2024-10-15

butyl-meta-cycloheptylprodiginine

Description

butyl-meta-cycloheptylprodiginine: from actinomycete strain B 4358; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID135515502
CHEMBL ID1812867
MeSH IDM0186401

Synonyms (6)

Synonym
cyclonona(b)pyrrole, 4-butyl-1,4,5,6,7,8,9,10-octahydro-2-((3-methoxy-5-(1h-pyrrol-2-yl)-2h-pyrrol-2-ylidene)methyl)-
56208-07-2
butyl-meta-cycloheptylprodiginine
bmchp
streptorubin b
CHEMBL1812867

Dosage Studied

ExcerptReference
" Each analogue reduced parasitemia by more than 90% after 25 (mg/kg)/day dosing and in some cases provided a cure."( Antimalarial activity of natural and synthetic prodiginines.
Alhamadsheh, M; Challis, GL; Haynes, SW; Kelly, JX; Papireddy, K; Reynolds, KA; Salem, SM; Smilkstein, M, 2011
)
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID612143Antimalarial activity Plasmodium falciparum D6 after 72 hrs by SYBR Green I based fluorescence assay2011Journal of medicinal chemistry, Aug-11, Volume: 54, Issue:15
Antimalarial activity of natural and synthetic prodiginines.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (17)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (5.88)18.2507
2000's3 (17.65)29.6817
2010's12 (70.59)24.3611
2020's1 (5.88)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews2 (11.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other15 (88.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]